82 FR 44424 - Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Customer/Partner Service Surveys

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 82, Issue 183 (September 22, 2017)

The Food and Drug Administration (FDA or we) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

[Federal Register Volume 82, Number 183 (Friday, September 22, 2017)]
[Notices]
[Pages 44424-44425]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-20246]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0019]


Agency Information Collection Activities; Submission for Office 
of Management and Budget Review; Comment Request; Customer/Partner 
Service Surveys

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is announcing 
that a proposed collection of information has been submitted to the 
Office of Management and Budget (OMB) for review and clearance under 
the Paperwork Reduction Act of 1995.

DATES: Fax written comments on the collection of information by October 
23, 2017.

ADDRESSES: To ensure that comments on the information collection are 
received, OMB recommends that written comments be faxed to the Office 
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, 
Fax: 202-395-7285, or emailed to [email protected]. All 
comments should be identified with the OMB control number 0910-0360. 
Also include the FDA docket number found in brackets in the heading of 
this document.

FOR FURTHER INFORMATION CONTACT: Amber Sanford, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A-12M, 11601 
Landsdown St., North Bethesda, MD 20852, 301-796-8867, 
[email protected].

SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has 
submitted the following proposed collection of information to OMB for 
review and clearance.

Customer/Partner Service Surveys

OMB Control Number 0910-0360--Extension

    Under section 903 of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 393), FDA is authorized to conduct research and public 
information programs about regulated products and responsibilities of 
the Agency. Executive Order 12862, entitled, ``Setting Customer Service 
Standard,'' directs Federal Agencies that ``provide significant 
services directly to the public'' to ``survey customers to determine 
the kind and quality of services they want and their level of 
satisfaction with existing services.'' FDA is seeking OMB clearance to 
conduct a series of surveys to implement Executive Order 12862. 
Participation in the surveys is voluntary. This request covers 
customer/partner service surveys of regulated entities, such as food 
processors; cosmetic drug, biologic and medical device manufacturers; 
consumers; and health professionals. The request also covers 
``partner'' (State and local governments) customer service surveys.
    FDA will use the information from these surveys to identify 
strengths and weaknesses in service to customers/partners and to make 
improvements. The surveys will measure timeliness, appropriateness and 
accuracy of information, and courtesy and problem resolution in the 
context of individual programs.
    FDA estimates conducting 15 customer/partner service surveys per 
year, each requiring an average of 15 minutes for review and 
completion. We estimate respondents to these surveys to be between 100 
and 20,000 customers. Some of these surveys will be repeats of earlier 
surveys for purposes of monitoring customer/partner service and 
developing long-term data.
    In the Federal Register of June 7, 2017 (82 FR 26497), FDA 
published a 60-day notice requesting public comment on the proposed 
collection of information. No comments were received.
    FDA estimates the burden of this collection of information as 
follows:

[[Page 44425]]



                                 Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
                                                        Annual
          Type of survey               Number of     frequency per       Hours per response         Total hours
                                      respondents      response
----------------------------------------------------------------------------------------------------------------
Mail, telephone, web-based........          55,000               1  .25 (15 minutes)............          13,750
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.


    Dated: September 15, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-20246 Filed 9-21-17; 8:45 am]
 BILLING CODE 4164-01-P